Bashir, Qaiser <br/><br/>
Allogeneic Hematopoietic Cell Transplantation for Myeloma: When and in Whom Does It Work.  [electronic resource] 

 -  Current hematologic malignancy reports  04 2017 
 - 126-135 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1558-822X 
<br/><br/><label>Standard No.: </label>10.1007/s11899-017-0374-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials as Topic<br/>Combined Modality Therapy<br/>Graft vs Host Disease--etiology<br/>Graft vs Tumor Effect--immunology<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Killer Cells, Natural--immunology<br/>Maintenance Chemotherapy<br/>Multiple Myeloma--diagnosis<br/>Neoplasm, Residual--pathology<br/>Receptors, KIR--metabolism<br/>Retreatment<br/>Tissue Donors<br/>Transplantation Conditioning--adverse effects<br/>Transplantation, Autologous<br/>Transplantation, Homologous<br/>Transplantation, Isogeneic